About
Explore Cell Therapies

About Cell Therapies

Our Facility

View our Services

Partnerships and Collaborations

Careers at Cell Therapies

Contact us

Since 2003, Cell Therapies has manufactured cell therapies, ex vivo gene therapies, and regenerative medicine products under GMP standards to meet global regulatory requirements.

Learn about Cell Therapies
Services
Explore Services

Contract Manufacturing

Technology Transfer

Process Development

Analytical Testing and Development

Quality as a Service

Consulting and Advisory

Clinical Trial Support

Cryopreservation & Logistics

Digitalization & Automation

With over two decades of experience in GMP manufacturing of cell-based products, Cell Therapies is a trusted partner in transforming promising research into scalable, compliant, and commercially viable therapies.

Learn about Our Services
Facility
Careers
Explore Careers

Careers at Cell Therapies

View Current Opportunities

Upload your Resume

We are always on the lookout for curious minds, problem-solvers, and biotech enthusiasts to join our team. If you have a background in GMP manufacturing, QC, QA, engineering, or cell and gene therapy development, we would love to hear from you.

Find out about a career at Cell Therapies
News and Resources
Explore News and Resources

All News and Resources

News

Resources

Filter
All News
Resources

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing
Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing
Read More

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy
A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy
Read More

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region
Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region
Read More

Read the latest from Cell Therapies
Contact

News

The fast path to first-in-human cell therapy trials

The development of cell and gene therapies (CGT) holds enormous promise for treating many different…

Cell TherapiesSeptember 6, 2021

News

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesJune 21, 2021

News

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 30, 2021

News

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 6, 2021

News

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

Cell Therapies Pty Ltd interim CEO and Chief Scientific Officer A/Prof Dominic Wall has spoken…

Cell TherapiesMarch 5, 2021

News

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

Last week we announced the TGA approval for Cell Therapies to manufacture Novartis’ CAR-T therapy,…

Cell TherapiesFebruary 18, 2021

News

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Cell Therapies Pty Ltd, a contract manufacturing organisation located within the Peter MacCallum Cancer Centre,…

Cell TherapiesFebruary 11, 2021

News

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

The Board of Cell Therapies Pty Ltd (CTPL) has announced that Dr Dawn Driscoll will…

Cell TherapiesNovember 11, 2020

News

Better Diagnostic Technologies for Cancer Detection

Cell tracking case study “Better diagnostic technologies for cancer detection” has been published on the…

Cell TherapiesOctober 21, 2020

News

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre, in collaboration with RMIT University, the…

Cell TherapiesMay 29, 2020

News

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

While hospitals in many parts of the world have faced unprecedented challenges with routine clinical…

Cell TherapiesMay 28, 2020

News

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Health Minister Greg Hunt announces funding for Kymriah today at the Peter MacCallum Cancer Institute…

Cell TherapiesJanuary 28, 2020

Filter

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

News and Resources

The latest news and insights from Cell Therapies

The fast path to first-in-human cell therapy trials

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

Better Diagnostic Technologies for Cancer Detection

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate